70.87

1.42% 0.99

Revolution Medicines Inc (RVMD)

Overview News Price History Option Chain Financials Why RVMD Down? Discussions Forecast

Revolution Medicines Inc stock is traded at $70.87, with a volume of 1.94M. It is up +1.42% in the last 24 hours and up +32.49% over the past month. Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Previous Close:

$69.88

Open:

$70.07

24h Volume:

1.94M

Relative Volume:

0.88

Market Cap:

$13.70B

Revenue:

$29.52M

Net Income/Loss:

$-567.06M

P/E Ratio:

-19.36

EPS:

-3.66

Net Cash Flow:

$-551.11M

1W Performance:

+4.61%

1M Performance:

+32.49%

6M Performance:

+82.94%

1Y Performance:

+24.82%

1-Day Range:

$69.50

$71.97

1-Week Range:

$67.27

$72.72

52-Week Range:

$29.17

$72.72

Revolution Medicines Inc Stock (RVMD) Company Profile

Name

Revolution Medicines Inc

Sector

Healthcare (1129)

Industry

Biotechnology (632)

Phone

415-766-3638

Address

700 SAGINAW DR, REDWOOD CITY, CA

Employee

809

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

RVMD's Discussions on Twitter

Compare RVMD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RVMD Revolution Medicines Inc	70.87	13.51B	29.52M	-567.06M	-551.11M	-3.66
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-25	Initiated	Wolfe Research	Outperform
Nov-03-25	Initiated	RBC Capital Mkts	Outperform
Oct-21-25	Initiated	Mizuho	Outperform
Oct-16-25	Resumed	Stifel	Buy
Sep-12-25	Resumed	Raymond James	Strong Buy
Sep-05-25	Initiated	Truist	Buy
Aug-19-25	Initiated	Piper Sandler	Overweight
Aug-15-25	Initiated	Wells Fargo	Overweight
Jul-15-25	Initiated	Goldman	Buy
Jul-16-24	Reiterated	Needham	Buy
Jul-12-24	Initiated	Barclays	Overweight
Jul-08-24	Initiated	Jefferies	Buy
Apr-12-24	Reiterated	Needham	Buy
Apr-10-24	Upgrade	Raymond James	Outperform → Strong Buy
Mar-11-24	Initiated	Piper Sandler	Overweight
Jan-05-24	Upgrade	BofA Securities	Neutral → Buy
Jan-04-24	Initiated	Wedbush	Outperform
Nov-16-23	Initiated	Raymond James	Outperform
Feb-28-23	Upgrade	JP Morgan	Neutral → Overweight
Dec-14-22	Initiated	Needham	Buy
Oct-21-22	Initiated	Oppenheimer	Outperform
May-20-22	Initiated	BofA Securities	Neutral
Mar-01-22	Upgrade	Stifel	Hold → Buy
Sep-23-21	Initiated	Stifel	Hold
Aug-12-21	Downgrade	Goldman	Buy → Neutral
May-18-21	Initiated	Goldman	Buy
May-21-20	Initiated	H.C. Wainwright	Buy
Mar-09-20	Initiated	Cowen	Outperform
Mar-09-20	Initiated	Guggenheim	Buy
Mar-09-20	Initiated	JP Morgan	Neutral

View All

Revolution Medicines Inc Stock (RVMD) Latest News

01:38 AM

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

01:38 AM

Nov 22, 2025

Is Revolution Medicines Inc Equity Warrant a good long term investmentVolatility Adjusted Trading & Free Short-Term Trading Strategies - earlytimes.in

Nov 22, 2025

Westfield Capital Management Co. LP Increases Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat

Nov 22, 2025

Neo Ivy Capital Management Invests $1.14 Million in Revolution Medicines, Inc. $RVMD - MarketBeat

Nov 22, 2025